All Cases

The case was approved based on the petitioner's record of 8 peer-reviewed journal articles and 105 citations, demonstrating international recognition. Additionally, the petitioner's participation in over 30 peer reviews for high-impact journals and receipt of major funding from NIGMS and NIAID satisfied the EB-1B criteria.

The case was approved based on the petitioner's international recognition as an outstanding researcher, supported by 8 peer-reviewed journal articles and 435 citations. The petitioner also demonstrated professional standing through 17 manuscript reviews for journals in the field. The research's practical application in small electronics and its support from the National Institute of Food and Agriculture further validated its significance.

The case was approved based on the petitioner's record of 10 peer-reviewed journal articles and 303 citations, placing them in the top 1% of highly cited authors. The petitioner also demonstrated expert authority through 18 peer reviews and editorial board membership. The research's alignment with national health priorities and support from major institutions like the NIH and NCI further satisfied the EB-1B requirements.

The approval was based on the petitioner's 1,399 citations and authorship of 14 peer-reviewed journal articles, including 4 first-authored papers. The case demonstrated international recognition through citations spanning five continents and a record of peer-reviewing at least 13 manuscripts. These metrics satisfied the EB-1B criteria for outstanding research contributions and scholarly publications.

The petition was approved based on the client's 583 citations, which placed them in the top 1% of highly cited authors in their field. Evidence included 9 peer-reviewed journal articles, a book chapter, and 16 peer reviews for acclaimed journals. The case satisfied EB-1B criteria by demonstrating international recognition through high citation metrics and sustained research impact funded by the NSF.

The petition was approved based on the petitioner's 14 peer-reviewed journal articles and 655 citations, which established his international influence in cell biology. His completion of 25 peer reviews for leading journals satisfied the judging criteria for EB-1B. The evidence successfully demonstrated his original scientific research contributions to the field of cancer treatment and molecular biochemistry.

The petition was approved based on 12 peer-reviewed journal articles and 647 citations demonstrating significant influence. The petitioner also provided evidence of 10 manuscript reviews and research funding from prestigious institutions like the NIH. These metrics satisfied the EB-1B criteria for scholarly publications, original contributions, and peer review.

The petition was approved based on 14 peer-reviewed articles, 10 conference abstracts, and 374 citations indicating global influence. The petitioner satisfied EB-1B criteria through her 18 peer reviews for prestigious journals like Science Translational Medicine and her leadership in federally funded NIH projects. Her research into protein degradation and lymphatic circulation was recognized for addressing pressing clinical needs in fracture healing.

The petition was approved based on a record of 9 peer-reviewed journal articles and 132 citations, demonstrating significant impact in structural biology. The petitioner also satisfied the peer review criterion by completing at least 40 reviews for respected journals. Furthermore, the research was supported by prestigious federal funding from the NIH and NSF, affirming the work's importance to U.S. national health interests.

The petition was approved based on 13 peer-reviewed journal articles and 4 abstracts which garnered 2,132 citations, demonstrating significant impact. The petitioner also completed 20 peer reviews for professional journals, satisfying the judging criterion. The evidence established international recognition for original contributions to cancer cell-free DNA epigenetics and single-cell genomics.